Kadcyla 160 mg powder for concentrate for solution for infusion. clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A phase II trial of an individualized treatment strategy for patients with metastatic non-clear cell renal carcinoma
This study is testing different medicines for people with advanced kidney cancer (non-clear cell renal carcinoma) that has spread. It's looking for personalised treatments to see which ones shrink the cancer and how long they keep it under control. The goal is to find better ways to treat this type of cancer.
For: Metastatic non-clear cell renal cell carcinomaDenmark - AuthorisedTherapeutic confirmatory (Phase III)
Atezolizumab, Pertuzumab and Trastuzumab with chemotherapy as neoadjuvant treatment of HER2 positive early high-risk and locally advanced breast cancer (APTneo)
This study looks at new drug combinations for women with a certain type of aggressive breast cancer before surgery. It aims to see if these treatments can stop the cancer from coming back and improve long-term health, comparing their effects and safety.
For: Invasive Breast CancerSpain · Germany · Italy - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase IIIB, Multinational, Multicenter, Randomized, Open-Label Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administrationin Participants with Early or Locally Advanced/ Inflammatory HER2-Positive Breast Cancer
This study looks at treating HER2-positive breast cancer. It compares giving a special medicine called Phesgo at home versus in the hospital to see which patients prefer. Researchers also check how well the treatment works and any side effects.
For: Early or Locally Advanced/ Inflammatory HER2-Positive Breast CancerSpain · Bulgaria · Croatia